Latest News

April 17th 2013

AmpliPhi Establishes Collaboration with Intrexon

Read full article...

February 04th 2013

AmpliPhi Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy

Read full article...

November 13th 2012

AmpliPhi and Special Phage Services Complete Merger

Read full article...

October 19th 2012

Ampliphi Presents Encouraging Pre-Clinical Data on Phage Therapies to Treat Bacterial Lung Infection

Read full article...

October 12th 2012

AmpliPhi CSO Dr. David Harper presents at NACFC 2012

Read full article...

September 10th 2012

AmpliPhi acquires Special Phage Services, forms World’s Leading Phage Therapy Company

Read full article...

September 10th 2012

AmpliPhi Featured on BBC Horizon

Read full article...

March 27th 2012

“Using Viruses to Beat Superbugs,” AmpliPhi CSO Dr. David Harper featured in ScienceDaily

Read full article...

March 08th 2012

“The Bacteriophage Comes of Age” in Medscape News

Read full article...

January 31st 2012

January 2012 Shareholder Letter

Read full article...

January 04th 2012

BioWorld Today features AmpliPhi CEO Phil Young

Read full article...

November 21st 2011

AmpliPhi Biosciences Announces First Closing of $2.7m

Read full article...

November 08th 2011

AmpliPhi Biosciences appoints Philip J. Young as President and CEO

Read full article...

September 06th 2011

AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York

Read full article...

August 09th 2011

Edison Investment Research releases “Antibiotic Amplifier”, an assessment of AmpliPhi Biosciences

Read full article...

July 14th 2011

Scientists Explore Alternative to Antibiotics

Read full article...

April 11th 2011

AmpliPhi Biosciences Announces UK Grant Award to develop its Novel Antimicrobial Technology

Read full article...

March 09th 2011

Targeted Genetics Announces Name Change to AmpliPhi Biosciences and Highlights Strategic Development

Read full article...